Viking Therapeutics, Inc. (VKTX)
29.30
+0.86
(+3.02%)
USD |
NASDAQ |
Feb 09, 16:00
29.20
-0.10
(-0.34%)
Pre-Market: 09:12
Viking Therapeutics EPS Diluted (Quarterly) : -0.8083 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 7.390 |
| Pfizer Inc. | -0.2898 |
| Amgen, Inc. | 2.45 |
| Biogen, Inc. | -0.3333 |
| Regeneron Pharmaceuticals, Inc. | 7.857 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -90.79M |
| Total Expenses (Quarterly) | 90.79M |
| Enterprise Value | 2.598B |
| Earnings Yield | -7.23% |
| Normalized Earnings Yield | -7.230 |